Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
AMRS [NASD]
Amyris, Inc.
Basic Materials | Specialty Chemicals | USA
statements
Index- P/E- EPS (ttm)-1.87 Insider Own33.01% Shs Outstand227.27M Perf Week3.10%
Market Cap2.93B Forward P/E- EPS next Y-0.37 Insider Trans0.00% Shs Float154.20M Perf Month41.00%
Income-350.90M PEG- EPS next Q-0.09 Inst Own42.00% Short Float15.51% Perf Quarter545.37%
Sales133.90M P/S21.89 EPS this Y27.80% Inst Trans-5.89% Short Ratio4.89 Perf Half Y332.15%
Book/sh-0.39 P/B- EPS next Y72.90% ROA-179.60% Target Price12.00 Perf Year345.29%
Cash/sh0.19 P/C76.53 EPS next 5Y30.00% ROE242.80% 52W Range1.40 - 18.57 Perf YTD137.25%
Dividend- P/FCF- EPS past 5Y-51.90% ROI- 52W High-17.72% Beta1.05
Dividend %- Quick Ratio0.90 Sales past 5Y28.70% Gross Margin37.70% 52W Low991.43% ATR1.74
Employees561 Current Ratio1.30 Sales Q/Q-2.00% Oper. Margin- RSI (14)60.86 Volatility14.45% 12.95%
OptionableYes Debt/Eq- EPS Q/Q34.40% Profit Margin- Rel Volume0.49 Prev Close14.65
ShortableYes LT Debt/Eq- EarningsMar 02 BMO Payout- Avg Volume4.89M Price15.28
Recom1.50 SMA2019.13% SMA5062.44% SMA200210.84% Volume1,991,059 Change4.30%
Jan-06-21Upgrade Cowen Market Perform → Outperform $9
Nov-25-20Initiated Jefferies Buy $3.35
Nov-25-20Initiated Cowen Market Perform $5
Dec-12-19Initiated Oppenheimer Outperform $8
Nov-14-18Reiterated B. Riley FBR Buy $10 → $8
Jan-25-18Initiated B. Riley FBR, Inc. Buy $8
May-28-14Resumed Stifel Hold
Feb-10-12Downgrade Deutsche Bank Buy → Hold $20 → $9
Nov-02-11Downgrade Robert W. Baird Outperform → Neutral $25 → $16
Jan-28-11Downgrade Stifel Nicolaus Buy → Hold
Nov-08-10Initiated Stifel Nicolaus Buy $22
Feb-24-21 08:00AM  
Amyris Announces Launch of Pipette® Clean Baby Care Brand in Target Retail Stores Across North America
PR Newswire
Feb-22-21 08:00AM  
Amyris Announces Positive Pre-Clinical Results For COVID-19 RNA Vaccine Platform With Advantaged Manufacturing, Storage And Distribution Characteristics
PR Newswire
Feb-17-21 08:00AM  
Amyris To Host Fourth Quarter And Full Year 2020 Financial Results Conference Call On March 2
PR Newswire
Feb-10-21 08:00AM  
Amyris Hosts Successful Second Session Of Its Virtual Investor Mini-Series
PR Newswire +6.46%
Feb-03-21 08:00AM  
Amyris to Host Second Webinar in its Virtual Investor Mini-Series
PR Newswire +21.05%
Feb-02-21 08:00AM  
Amyris Announces Breakthrough Clinical Results For Its Clean Formulation Acne Treatment
PR Newswire
Jan-26-21 04:08PM  
Top Marijuana Stocks for February 2021
Investopedia +5.90%
Jan-22-21 10:50PM  
AMYRIS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Amyris, Inc. - AMRS
Business Wire
08:00AM  
Amyris Acquiring Terasana Brand To Offer Clean Cannabinoid Consumer Products
PR Newswire
Jan-21-21 04:23PM  
Top Marijuana Stocks on the NASDAQ for February 2021
Investopedia -6.03%
Jan-15-21 08:00AM  
Amyris Ranked Among World's Top Social And Environmental Impact Companies By Real Leaders®
PR Newswire +8.04%
Jan-11-21 08:00AM  
Amyris Creates Partnership With Jonathan Van Ness To Launch Leading Clean Haircare Brand
PR Newswire +8.16%
Jan-04-21 08:00AM  
Amyris To Launch Its Biossance TM Clean Beauty Brand In China Through Partnership With Superordinary
PR Newswire +13.68%
Dec-28-20 08:00AM  
Amyris Announces Bonsucro Certification Sustainable Sugarcane Production For Clean Ingredients
PR Newswire +10.11%
Dec-24-20 08:52AM  
Are Options Traders Betting on a Big Move in Amyris (AMRS) Stock?
Zacks
Dec-21-20 09:30AM  
SHAREHOLDER ALERT: Amyris, Inc. (NASDAQ: AMRS) Officers and Directors Under Investigation for Possible Breaches of Fiduciary Duty
PR Newswire +10.98%
08:44AM  
Amyris (AMRS) Surges: Stock Moves 7.1% Higher
Zacks
08:00AM  
Amyris Closes $50 Million Strategic Transaction
PR Newswire
Dec-16-20 08:00AM  
Amyris Hosts Successful First Session Of Its Virtual Investor Mini-Series
PR Newswire +20.47%
Dec-11-20 10:34AM  
Is AMRS A Good Stock To Buy Now?
Insider Monkey +8.72%
Dec-08-20 09:00AM  
Purecane, the Revolutionary Sweetener Derived from Sugarcane, Wins 2020 Popular Science Best of What's New Award
PR Newswire
Dec-03-20 08:00AM  
Amyris Launches Virtual Investor Mini-Series
PR Newswire
Nov-30-20 08:00AM  
Amyris Delivers Record Black Friday Sales
PR Newswire
Nov-23-20 08:00AM  
Amyris To Present at Evercore ISI's 3rd Annual HealthCONx Conference on December 3, 2020
PR Newswire +5.22%
Nov-18-20 10:23AM  
New Strong Sell Stocks for November 18th
Zacks
Nov-05-20 08:00AM  
Amyris, Inc. Reports Third Quarter 2020 Financial Results
PR Newswire -19.01%
Oct-30-20 08:00AM  
Amyris And Rosie Huntington-Whiteley Announce Creation Of New Clean Beauty Brand And Business Partnership
PR Newswire -5.66%
Oct-26-20 11:00AM  
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors
Business Wire -6.23%
Oct-23-20 07:06PM  
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors
Business Wire +7.02%
08:00AM  
Amyris To Host Third Quarter 2020 Financial Results Conference Call On November 5
PR Newswire
Oct-22-20 08:00AM  
Amyris and The Infectious Disease Research Institute Enter into Exclusive License for Novel RNA Vaccine Platform, Beginning with COVID-19 Vaccine
PR Newswire
Oct-20-20 09:30AM  
Amyris and Arzeda Enter into Development Collaboration Agreement
PR Newswire
Oct-09-20 09:00AM  
Kaskela Law LLC Announces Stockholder Investigation of Amyris, Inc. (AMRS) and Encourages Long-Term Investors to Contact the Firm
PR Newswire
Oct-08-20 09:00AM  
The Law Offices of Frank R. Cruz Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors
Business Wire
Oct-07-20 09:22AM  
Why Amyris Fell 11% in September
Motley Fool
Oct-01-20 08:30AM  
Amyris Delivering Sustainable Alternative To Shark Squalene Adjuvant - Enabling Vaccines For All With No Sharks Killed
PR Newswire +6.51%
Sep-22-20 07:00PM  
Media Advisory - Canfor Corporation and Canfor Pulp Products Inc. Announce Third Quarter Results Conference Call
CNW Group
Sep-21-20 08:30AM  
Amyris' Pipette Clean Baby Brand Selected By Alibaba For Accelerated Entry Into China For Singles' Day Sales
PR Newswire
Sep-15-20 08:30AM  
Amyris Continues Market Adoption Of Its Sweetener With Approval By Health Canada
PR Newswire +8.26%
Sep-14-20 07:00AM  
Amyris to Provide Business Overview And Update On Current Affairs At H.C. Wainwright 22nd Annual Global Investment Conference Today
PR Newswire
Sep-11-20 04:22PM  
Why Amyris Shares Dropped 26% Today
Motley Fool -25.80%
03:25PM  
Amyris Denies 'Patent Infringement' Allegations On Heels Of $881M Lavvan Lawsuit
Benzinga
05:00AM  
Amyris Responds To LAVVAN's Filing Of Lawsuit On September 10, 2020
PR Newswire
Sep-10-20 03:41PM  
LAVVAN, Inc. Files $881 Million Federal Lawsuit Against Amyris, Inc. For Patent Infringement and Trade Secret Misappropriation
PR Newswire
Sep-08-20 08:30AM  
Amyris to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020
PR Newswire
Sep-04-20 08:50AM  
New Strong Sell Stocks for September 4th
Zacks -6.44%
Sep-01-20 03:30PM  
Oppenheimer: These 3 Penny Stocks Have Triple-Digit Upside Potential
TipRanks
08:30AM  
Amyris Scales First Fermentation-Based Cannabinoid
PR Newswire
08:30AM  
Amyris Scales First Fermentation-Based Cannabinoid
CNW Group
Aug-20-20 08:31AM  
Should Amyris Split Into 2 Companies?
Motley Fool
Aug-14-20 08:30AM  
Amyris Appoints Sheila Shekar Pollak As Chief Marketing Officer Of Biossance
PR Newswire -5.50%
Aug-06-20 08:30AM  
Amyris, Inc. Reports Second Quarter 2020 Results
PR Newswire -18.32%
Jul-29-20 05:01PM  
Rigrodsky & Long, P.A. Files Class Action Suit Against Amyris, Inc.
GlobeNewswire
12:25PM  
INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of Amyris, Inc. - AMRS
PR Newswire
Jul-28-20 09:07PM  
SHAREHOLDER ALERT: WeissLaw LLP Investigates Amyris, Inc.
PR Newswire
Jul-27-20 12:41PM  
Here's Why Amyris Stock Rose as Much as 12.2% Today
Motley Fool +6.57%
08:30AM  
Amyris and The Infectious Disease Research Institute Partner to Advance Novel RNA Vaccine Platform Beginning With COVID-19 Application
PR Newswire
Jul-23-20 08:30AM  
Amyris To Host Second Quarter 2020 Financial Results Conference Call On August 6
PR Newswire
Jul-20-20 01:29PM  
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Business Wire
01:20PM  
IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm
ACCESSWIRE
09:53AM  
INVESTIGATION ALERT: Labaton Sucharow is Investigating Amyris, Inc. for Potential Securities Violations and Breach of Fiduciary Duty (NASDAQ:AMRS)
ACCESSWIRE
Jul-18-20 11:16AM  
INVESTIGATION ALERT: Labaton Sucharow is Investigating Amyris, Inc. for Potential Securities Violations and Breach of Fiduciary Duty (NASDAQ:AMRS)
ACCESSWIRE
Jul-17-20 12:40PM  
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm
ACCESSWIRE
Jul-16-20 07:25PM  
ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
06:31PM  
INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Amyris, Inc. and Encourages Investors With Losses in Excess of $100,000 to Contact the Firm
Business Wire
Jul-15-20 03:40PM  
INVESTIGATION ALERT: Labaton Sucharow is Investigating Amyris, Inc. for Potential Securities Violations and Breach of Fiduciary Duty (NASDAQ: AMRS)
ACCESSWIRE -6.35%
08:30AM  
Amyris Launches Plant-derived Sustainable Silica for Clean Beauty Applications
PR Newswire
Jul-09-20 10:00AM  
INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Amyris, Inc. for Potential Breach of Fiduciary Duty Claims
ACCESSWIRE -5.63%
Jul-02-20 10:39PM  
Implied Volatility Surging for Amyris (AMRS) Stock Options
Zacks +5.52%
Jun-30-20 08:30AM  
Biossance Announces Clean Academy Impact Award and Partnership With Oceana
PR Newswire
Jun-29-20 12:00PM  
Low-Priced Amyris Could Surprise on the Upside
TheStreet.com
Jun-22-20 08:30AM  
Amyris Partners With AB Mauri North America To Reduce Sugar In Baking Products Using PURECANE Sweetener
PR Newswire +12.50%
Jun-10-20 08:30AM  
Amyris Announces Closing Of $200 Million Private Placement
PR Newswire -6.37%
Jun-04-20 08:58AM  
Amyris Raises $200 Million From Private Placement
PR Newswire
Jun-02-20 08:37AM  
Edited Transcript of AMRS earnings conference call or presentation 8-May-20 1:00pm GMT
Thomson Reuters StreetEvents -9.16%
Jun-01-20 05:31PM  
Stock Market Wrap-Up: Why These 2 Under-the-Radar Stocks Jumped Monday
Motley Fool +43.43%
12:29PM  
Here's Why Amyris Is Soaring Today
Motley Fool
12:00PM  
This Could Be the Next Big Pot Stock
Motley Fool
May-27-20 01:33PM  
Penny Stocks to Watch for June 2020
Investopedia -5.62%
May-21-20 09:18AM  
Amyris Launches Safe Alternative To Talc-Based Baby Powder
PR Newswire
May-17-20 08:00PM  
Is Another Accounting Issue Brewing for Amyris?
Motley Fool
May-15-20 08:30AM  
Amyris Changes its 2020 Annual Meeting of Stockholders to Virtual Format
PR Newswire +9.24%
May-14-20 09:36AM  
Is Amyris Finally Turning a Corner?
Motley Fool
08:30AM  
Amyris Receives GRAS Validation by Medical Expert Panel for its New Health and Nutrition Ingredient
PR Newswire
May-08-20 08:30AM  
Amyris, Inc. Reports First Quarter 2020 Results
PR Newswire +6.35%
May-07-20 08:30AM  
Amyris to Participate in the Oppenheimer 5th Annual Emerging Growth Conference on May 12
PR Newswire +7.69%
May-04-20 08:30AM  
Amyris To Host First Quarter 2020 Financial Results Conference Call On May 8
PR Newswire
Apr-21-20 07:10PM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Amyris, Inc.- AMRS
ACCESSWIRE
Apr-20-20 08:30AM  
Amyris Receives Approval to Sell its Fermented Sugarcane Reb M in Brazil and Canada
PR Newswire
Apr-13-20 07:30AM  
Amyris Experiences Very Strong Sales Start with Pipette Hand Sanitizer for the Whole Family
PR Newswire -5.67%
Mar-31-20 08:30AM  
Amyris Scales Up in Response to High Need for Its Hand Sanitizer and Wipe Products
PR Newswire
Mar-26-20 08:30AM  
Amyris Launches Leading Hand Sanitizer and Receives Initial Positive Result for Vaccine Adjuvant
PR Newswire +8.96%
Mar-24-20 10:01PM  
Edited Transcript of AMRS earnings conference call or presentation 12-Mar-20 8:30pm GMT
Thomson Reuters StreetEvents +10.82%
Mar-23-20 06:13AM  
Should You Worry About Amyris, Inc.'s (NASDAQ:AMRS) CEO Pay Cheque?
Simply Wall St. -13.00%
Mar-16-20 08:05AM  
Amyris Provides Business Update
PR Newswire -14.67%
Mar-12-20 04:15PM  
Amyris Reports Another Strong Quarter of Recurring Revenue Growth
PR Newswire -10.14%
02:30PM  
Amyris, Inc. to Host Earnings Call
ACCESSWIRE
Mar-10-20 08:30AM  
Amyris to Participate in Fireside Chat at 32nd Annual Roth Conference on March 16, 2020
PR Newswire
Mar-09-20 08:30AM  
Amyris Expands Distribution of PURECANE Baking Sweetener on Amazon Strong Early Sales
PR Newswire -15.00%
Mar-06-20 08:30AM  
Amyris Discovers Major Breakthrough in CBD Delivery
PR Newswire
Amyris, Inc., a biotechnology company, develops technology that creates microbial strains to produce artemisinic acid, a precursor of artemisinin, an anti-malarial drug. The company's technology platform enables to engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into large volume, high-value ingredients. It applies technology platform to engineer, manufacture, and sell products for the clean health and beauty, and flavor and fragrance markets. The company operates under the Amyris, Biofene, Biossance, Pipette, Purecane, and No Compromise trademarks. Amyris, Inc. has a collaboration agreement with the Infectious Disease Research Institute to advance a novel ribonucleic acid vaccine platform, including accelerating the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DOERR L JOHNDirectorDec 11Option Exercise2.875,000,00014,350,00070,156,794Dec 15 07:18 PM
Kung FrankDirectorJun 05Buy3.003,689,22511,067,6756,284,876Jun 09 09:06 PM
DOERR L JOHNDirectorMar 11Option Exercise2.875,226,48115,000,00058,490,128Mar 13 08:26 PM
open in yahoo | open in reuters | open in google
affiliate • advertise • contact • privacy • help
Do not sell my personal information
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2021 FINVIZ.com. All Rights Reserved.